The Promise Of Low Dose Naltrexone Therapy: Potential Benefits

The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders

Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS).
Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.
Country USA
Brand McFarland
Manufacturer McFarland & Company
Binding Paperback
ItemPartNumber photos, glossary, notes, bibliography, i
UnitCount 1
EANs 9780786437153
ReleaseDate 0000-00-00

Country	USA
Brand	McFarland
Manufacturer	McFarland & Company
Binding	Paperback
ItemPartNumber	photos, glossary, notes, bibliography, i
UnitCount	1
EANs	9780786437153
ReleaseDate	0000-00-00

The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders